Head and neck cancer in the elderly: An overview on the treatment modalities

Cancer Treatment Reviews

Volumn 35, Issue 3, 2009, Pages 237-245

  Syrigos, Kostas N ^a   Karachalios, Dimitris ^a   Karapanagiotou, Eleni M ^a,b   Nutting, Christopher M ^b   Manolopoulos, Leonidas ^c   Harrington, Kevin J ^b  

^a SOTIRIA GENERAL HOSPITAL   (Greece)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

^c HIPPOKRATION HOSPITAL   (Greece)

Author keywords

Chemotherapy; Elderly; Geriatric assessment; Head and neck cancer; Multidisciplinary approach; Radiotherapy; Surgery

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CETUXIMAB; CISPLATIN; DOCETAXEL; FLUOROURACIL; GRANULOCYTE COLONY STIMULATING FACTOR; PACLITAXEL;

ANEMIA; BLEEDING; BONE MARROW TOXICITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CARDIOTOXICITY; CHEMOTHERAPY INDUCED EMESIS; CLINICAL TRIAL; COMORBIDITY; DIARRHEA; DISEASE FREE SURVIVAL; DRUG DOSE COMPARISON; ELDERLY CARE; FEBRILE NEUTROPENIA; FUNCTIONAL STATUS; GERIATRIC ASSESSMENT; HEAD AND NECK CANCER; HEMATOLOGIC DISEASE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MOUTH ULCER; MUCOSA INFLAMMATION; MUCOSAL DISEASE; MULTIMODALITY CANCER THERAPY; NAUSEA; NEPHROTOXICITY; NEUROTOXICITY; NEUTROPENIA; OVERALL SURVIVAL; PATIENT SELECTION; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; QUALITY OF LIFE; RADIATION DOSE FRACTIONATION; RADIATION INJURY; REVIEW; SEPSIS; SQUAMOUS CELL CARCINOMA; SURGICAL TECHNIQUE; SURVIVAL RATE; THROMBOCYTOPENIA; TOOTH DISEASE; TREATMENT PLANNING;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; COMORBIDITY; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; INTERDISCIPLINARY COMMUNICATION; MALE; PATIENT CARE TEAM; POSTOPERATIVE COMPLICATIONS; RADIOTHERAPY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SPECIALTIES, MEDICAL; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 64049101544     PISSN: 03057372     EISSN: 15321967     Source Type: Journal    
DOI: 10.1016/j.ctrv.2008.11.002     Document Type: Review

References (85)

1. Vercelli M., Parodi S., and Serraino D. Overall cancer incidence and mortality trends among elderly and adult Europeans. Crit Rev Oncol Hematol 27 (1998) 87-96
2. Parker S.L., Tong T., Bolden S., and Wingo P.A. Cancer statistics, 1997. CA Cancer J Clin 47 (1997) 5-27
3. Yancik R., and Ries L.A. Cancer in older persons magnitude of the problem - how do we apply what we know?. Cancer 74 (1994) 1995-2003
4. Socinski M.A., Morris D.E., Masters G.A., and Lilenbaum R. Chemotherapeutic management of stage IV non-small cell lung cancer. Chest 123 (2003) 226S-243S
5. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 55 (2005) 74-108
6. Balducci L. Management of cancer in the elderly. Oncology (Williston Park) 20 (2006) 135-143
7. Muir C.S., Fraumeni Jr. J.F., and Doll R. The interpretation of time trends. Cancer Surv 19-20 (1994) 5-21
8. Pignon T., Horiot J.C., Van den B.W., Van G.M., and Scalliet P. No age limit for radical radiotherapy in head and neck tumours. Eur J Cancer 32A (1996) 2075-2081
9. Koch W.M., Patel H., Brennan J., Boyle J.O., and Sidransky D. Squamous cell carcinoma of the head and neck in the elderly. Arch Otolaryngol Head Neck Surg 121 (1995) 262-265
10. Argiris A., and Eng C. Epidemiology, staging, and screening of head and neck cancer. Cancer Treat Res 114 (2003) 15-60
11. Leon X., Quer M., Agudelo D., et al. Influence of age on laryngeal carcinoma. Ann Otol Rhinol Laryngol 107 (1998) 164-169
12. Sarini J., Fournier C., Lefebvre J.L., Bonafos G., Van J.T., and Coche-Dequeant B. Head and neck squamous cell carcinoma in elderly patients: a long-term retrospective review of 273 cases. Arch Otolaryngol Head Neck Surg 127 (2001) 1089-1092
13. Lusinchi A., Bourhis J., Wibault P., Le Ridant A.M., and Eschwege F. Radiation therapy for head and neck cancers in the elderly. Int J Radiat Oncol Biol Phys 18 (1990) 819-823
14. Jones A.S., Husband D., and Rowley H. Radical radiotherapy for squamous cell carcinoma of the larynx, oropharynx and hypopharynx: patterns of recurrence, treatment and survival. Clin Otolaryngol Allied Sci 23 (1998) 496-511
15. Hirano M., and Mori K. Management of cancer in the elderly: therapeutic dilemmas. Otolaryngol Head Neck Surg 118 (1998) 110-114
16. Argiris A., Karamouzis M.V., Raben D., and Ferris R.L. Head and neck cancer. Lancet 371 (2008) 1695-1709
17. Balducci L., and Beghe' C. Cancer and age in the USA. Crit Rev Oncol Hematol 37 (2001) 137-145
18. Syrigos K.N., Karapanagiotou E., Charpidou A., et al. Biweekly administration of docetaxel and gemcitabine for elderly patients with advanced non-small cell lung cancer: a phase II study. J Chemotherapy 19 (2007) 438-443
19. Reid B.C., Alberg A.J., Klassen A.C., et al. Comorbidity and survival of elderly head and neck carcinoma patients. Cancer 92 (2001) 2109-2116
20. Extermann M., Overcash J., Lyman G.H., Parr J., and Balducci L. Comorbidity and functional status are independent in older cancer patients. J Clin Oncol 16 (1998) 1582-1587
21. Read W.L., Tierney R.M., Page N.C., et al. Differential prognostic impact of comorbidity. J Clin Oncol 22 (2004) 3099-3103
22. Balducci L., and Ershler W.B. Cancer and ageing: a nexus at several levels. Nat Rev Cancer 5 (2005) 655-662
23. Lee S.J., Lindquist K., Segal M.R., and Covinsky K.E. Development and validation of a prognostic index for 4-year mortality in older adults. JAMA 295 (2006) 801-808
24. Balducci L., Cohen H.J., Engstrom P.F., et al. Senior adult oncology clinical practice guidelines in oncology. J Natl Compr Cancer Netw 3 (2005) 572-590
25. Ingram S.S., Seo P.H., Martell R.E., et al. Comprehensive assessment of the elderly cancer patient: the feasibility of self-report methodology. J Clin Oncol 20 (2002) 770-775
26. Balducci, L. Cancer in the older person. American society on aging; 2006. p. 45-50. Ref type: conference proceeding.
27. Bernardi D., Barzan L., Franchin G., et al. Treatment of head and neck cancer in elderly patients: state of the art and guidelines. Crit Rev Oncol Hematol 53 (2005) 71-80
28. NCCN Practice guidelines in oncology-senior adult oncology v.; 2007 MS4-8. Ref type: electronic citation.
29. Audiosio R.A., Pope D., Ramesh H.S., et al. Shall we operate? Preoperative assessment in elderly cancer patients (PACE) can help. A SIOG surgical task force prospective study. Crit Rev Hematol 65 (2008) 156-163 PACE participants
30. Teymoortash A., Wulf H., and Werner J.A. Head and neck cancer surgery in the elderly. Laryngorhinootologie 81 (2002) 293-298
31. Scotish intercollegiate guidelines network. Diagnosis and management of head and neck cancer. Scottish intercollegiate guidelines network; 2006. Ref. type: electronic citation.
32. McGuirt W.F., Loevy S., McCabe B.F., and Krause C.J. The risks of major head and neck surgery in the aged population. Laryngoscope 87 (1977) 1378-1382
33. Morgan R.F., Hirata R.M., Jaques D.A., and Hoopes J.E. Head and neck surgery in the aged. Am J Surg 144 (1982) 449-451
34. Zabrodsky M., Calabrese L., Tosoni A., et al. Major surgery in elderly head and neck cancer patients: immediate and long-term surgical results and complication rates. Surg Oncol 13 (2004) 249-255
35. Laccourreye O., Brasnu D., Perie S., Muscatello L., Menard M., and Weinstein G. Supracricoid partial laryngectomies in the elderly: mortality, complications, and functional outcome. Laryngoscope 108 (1998) 237-242
36. Shestak K.C., Jones N.F., Wu W., Johnson J.T., and Myers E.N. Effect of advanced age and medical disease on the outcome of microvascular reconstruction for head and neck defects. Head Neck 14 (1992) 14-18
37. Bridger A.G., O'Brien C.J., and Lee K.K. Advanced patient age should not preclude the use of free-flap reconstruction for head and neck cancer. Am J Surg 168 (1994) 425-428
38. Malata C.M., Cooter R.D., Batchelor A.G., Simpson K.H., Browning F.S., and Kay S.P. Microvascular free-tissue transfers in elderly patients: the leeds experience. Plast Reconstr Surg 98 (1996) 1234-1241
39. Shaari C.M., Buchbinder D., Costantino P.D., Lawson W., Biller H.F., and Urken M.L. Complications of microvascular head and neck surgery in the elderly. Arch Otolaryngol Head Neck Surg 124 (1998) 407-411
40. Pompei S., Tedesco M., Pozzi M., Varanese A., Barile A., and Marzetti F. Age as a risk factor in cervicofacial reconstruction. J Exp Clin Cancer Res 18 (1999) 209-212
41. Blackwell K.E., Azizzadeh B., Ayala C., and Rawnsley J.D. Octogenarian free flap reconstruction: complications and cost of therapy. Otolaryngol Head Neck Surg 126 (2002) 301-306
42. Moorthy S.S., and Radpour S. Management of anesthesia in geriatric patients undergoing head and neck surgery. Ear Nose Throat J 78 (1999) 496-498
43. Reppeto L., Fratino L., Audisio R., et al. Comprehensive geriatric assessment adds information to Eastern cooperative oncology group performance status in elderly cancer patients: an Italian group for geriatric oncology study. J Clin Oncol 15 (2002) 494-502
44. Boruk M., Chernobilsky B., Rosenfeld R.M., and Har-El G. Age as a prognostic factor for complications of major head and neck surgery. Arch Otolaryngol Head Neck Surg 131 (2005) 605-609
45. Sanabria A., Carvalho A.L., Vartanian J.G., Magrin J., Ikeda M.K., and Kowalski L.P. Comorbidity is a prognostic factor in elderly patients with head and neck cancer. Ann Surg Oncol 14 (2007) 1449-1457
46. Derks W., De Jr. L., Hordijk G.J., and Winnubst J.A. Elderly patients with head and neck cancer: short-term effects of surgical treatment on quality of life. Clin Otolaryngol Allied Sci 28 (2003) 399-405
47. Sanabria A., Carvalho A.L., Melo R.L., et al. Predictive factors for complications in elderly patients who underwent head and neck oncologic surgery. Head Neck 30 (2008) 170-177
48. Dhiwakar M., Khan N.A., and McClymont L.G. Surgery for head and neck skin tumors in the elderly. Head Neck 29 (2007) 851-856
49. Khafif A., Posen J., Yagil Y., et al. Quality of life in patients older than 75 years following major head and neck surgery. Head Neck 29 (2007) 932-939
50. Donato V., Valeriani M., and Zurlo A. Short course radiation therapy for elderly cancer patients. Evidences from the literature review. Crit Rev Oncol Hematol 45 (2003) 305-311
51. Nguyen L.N., and Ang K.K. Radiotherapy for cancer of the head and neck: altered fractionation regimens. Lancet Oncol 3 (2002) 693-701
52. Fu K.K., Pajak T.F., Trotti A., et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 48 (2000) 7-16
53. Bourhis J., Overgaard J., Audry H., et al. Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis. Lancet 368 (2006) 843-854
54. Guerrero Urbano M.T., Clark C.H., Kong C., et al. Target volume definition for head and neck intensity modulated radiotherapy: pre-clinical evaluation of PARSPORT trial guidelines. Clin Oncol (R Coll Radiol) 19 (2007) 604-613
55. Fielding A.L., Evans P.M., and Clark C.H. Verification of patient position and delivery of IMRT by electronic portal imaging. Radiother Oncol 73 (2004) 339-347
56. Eisbruch A., Marsh L.H., Dawson L.A., et al. Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing. Int J Radiat Oncol Biol Phys 59 (2004) 28-42
57. Urbano T.G., Clark C.H., Hansen V.N., et al. Intensity Modulated Radiotherapy (IMRT) in locally advanced thyroid cancer: acute toxicity results of a phase I study. Radiother Oncol 85 (2007) 58-63
58. Mitsuhashi N., Hayakawa K., Yamakawa M., et al. Cancer in patients aged 90 years or older: radiation therapy. Radiology 211 (1999) 829-833
59. Yamakawa M., Shiojima K., Takahashi M., et al. Radiation therapy for esophageal cancer in patients over 80 years old. Int J Radiat Oncol Biol Phys 30 (1994) 1225-1232
60. Zachariah B., Balducci L., Venkattaramanabalaji G.V., Casey L., Greenberg H.M., and DelRegato J.A. Radiotherapy for cancer patients aged 80 and older: a study of effectiveness and side effects. Int J Radiat Oncol Biol Phys 39 (1997) 1125-1129
61. Hishikawa Y., Kurisu K., Taniguchi M., Kamikonya N., and Miura T. Radiotherapy for carcinoma of the esophagus in patients aged eighty or older. Int J Radiat Oncol Biol Phys 20 (1991) 685-688
62. Schilcher B., and Curschmann J. Clinical results of radiotherapy in 140 elderly patients treated at Basel University Hospital between 1980 and 1985. Int J Radiat Oncol Biol Phys 33 (1995) 774
63. Huguenin P., Sauer M., Glanzmann C., and Lutolf U.M. Radiotherapy for carcinomas of the head and neck in elderly patients. Strahlenther Onkol 172 (1996) 485-488
64. Zachariah B., Balducci L., Venkattaramanabalaji G.V., Casey L., Greenberg H.M., and DelRegato J.A. Radiotherapy for cancer patients aged 80 and older: a study of effectiveness and side effects. Int J Radiat Oncol Biol Phys 39 (1997) 1125-1129
65. Schofield C.P., Sykes A.J., Slevin N.J., and Rashid N.Z. Radiotherapy for head and neck cancer in elderly patients. Radiother Oncol 69 (2003) 34-37
66. Oguchi M., Ikeda H., Watanabe T., et al. Experiences of 23 patients > or = 90 years of age treated with radiation therapy. Int J Radiat Oncol Biol Phys 41 (1998) 407-413
67. Allal A.S., Maire D., Becker M., and Dulguerov P. Feasibility and early results of accelerated radiotherapy for head and neck carcinoma in the elderly. Cancer 88 (2000) 648-652
68. Olmi P., Usili-Cefaro G., and Loreggian L. Radiation therapy in the elderly with head and neck cancer. Rays 22 (1997) 77-81
69. Kouvaris J.R., Kouloulias V.E., and Vlahos L.J. Amifostine: the first selective-target and broad-spectrum radioprotector. Oncologist 12 (2007) 738-747
70. Wasil T., Lichtman S.M., Gupta V., and Rush S. Radiation therapy in cancer patients 80 years of age and older. Am J Clin Oncol 23 (2000) 526-530
71. Geinitz H., Zimmermann F.B., and Molls M. Radiotherapy of the elderly patient. Radiotherapy tolerance and results in older patients. Strahlenther Onkol 175 (1999) 119-127
72. Bhide S.A., Ahmed M., Barbachano Y., Newbold K., Harrington K.J., and Nutting C.M. Sequential induction chemotherapy followed by radical chemo-radiation in the treatment of locoregionally advanced head-and-neck cancer. Br J Cancer 99 (2008) 57-62
73. Pignon J.P., Bourhis J., Domenge C., and Designe L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC collaborative group. meta-analysis of chemotherapy on head and neck cancer. Lancet 355 (2000) 949-955
74. Bernier J., Cooper J.S., Pajak T.F., et al. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501). Head Neck 27 (2005) 843-850
75. Posner M.R., Hershock D.M., Blajman C.R., et al. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med 357 (2007) 1705-1715
76. Vermorken J.B., Remenar E., Van H.C., et al. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med 357 (2007) 1695-1704
77. Cohen E.E., Lingen M.W., and Vokes E.E. The expanding role of systemic therapy in head and neck cancer. J Clin Oncol 22 (2004) 1743-1752
78. Argiris A., Li Y., Murphy B.A., Langer C.J., and Forastiere A.A. Outcome of elderly patients with recurrent or metastatic head and neck cancer treated with cisplatin-based chemotherapy. J Clin Oncol 22 (2004) 262-268
79. Syrigos K.N., Karapanagiotou E., and Harrington K.J. Prostate cancer in the elderly. Anticancer Res 25 (2005) 4527-4533
80. Repetto L. Greater risks of chemotherapy toxicity in elderly patients with cancer. J Support Oncol 1 (2003) 18-24
81. Bonner J.A., Harari P.M., Giralt J., et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 354 (2006) 567-578
82. Harari P.M., and Huang S.M. Head and neck cancer as a clinical model for molecular targeting of therapy: combining EGFR blockade with radiation. Int J Radiat Oncol Biol Phys 49 (2001) 427-433
83. Huang S.M., Bock J.M., and Harari P.M. Epidermal growth factor receptor blockade with C225 modulates proliferation, apoptosis, and radiosensitivity in squamous cell carcinomas of the head and neck. Cancer Res 59 (1999) 1935-1940
84. Huang S.M., and Harari P.M. Modulation of radiation response after epidermal growth factor receptor blockade in squamous cell carcinomas: inhibition of damage repair, cell cycle kinetics, and tumor angiogenesis. Clin Cancer Res 6 (2000) 2166-2174
85. van der Schroeff M.P., Derks W., Hordijk G.J., and de Leeuw R.J. The effect of age on survival and quality of life in elderly head and neck cancer patients: a long- term prospective study. Eur Arch Otorhinolaryngol 264 (2007) 415-422